The second wave of the pandemic has left us dealing with healthcare emergencies of a monumental scale. The number of new cases erupting every day is increasing. Increasing infection severity…
As we move closer to the day COVID-19 vaccines will be allowed for mass usage, the optimism in the air is progressively increasing.
Stock Markets across the world are scaling new peaks with many key variables indicating sustained rebound in economic activities. However one needs to view the current market sentiment with measured perspective and a practical approach. While the general optimism around launch of vaccines is running high, the on-the-ground situation will be challenging for implementation of mass immunization programs especially in a developing country like India of our size and population.(more…)
Christmas is approaching. Perhaps, this will be the first time the whole world wants the same secret wish to get fulfilled by Santa Claus: the discovery of an effective vaccine for the Coronavirus.(more…)
The story of India’s pharmaceuticals industry in the context of COVID-19
Not every extraordinary situation turns out to be unfavourable for an economy. There are sectors which benefit amply from extraordinary situations like the pandemic. One such sector is pharmaceuticals. The pandemic which had destroyed demand in most key sectors has clearly brought India’s pharmaceuticals sector at the centre of most analysis and predictions.(more…)
The Spanish flu, also known as the 1918 flu pandemic, was an unusually deadly influenza pandemic caused by the H1N1 influenza A virus. Lasting from February 1918 to April 1920, it infected 500 million people – about a third of the world’s population at the time – in four successive waves. The death toll is typically estimated to have been somewhere between 17 million and 50 million, and possibly as high as 100 million, making it one of the deadliest pandemics in human history.(more…)